We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+11.16%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$294M
AUM Growth
+$47M
Cap. Flow
+$52.7M
Cap. Flow %
17.92%
Top 10 Hldgs %
26.72%
Holding
84
New
21
Increased
28
Reduced
22
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$5.68M
2
GILD icon
Gilead Sciences
GILD
+$5.11M
3
AET
Aetna Inc
AET
+$4.9M
4
BSX icon
Boston Scientific
BSX
+$4.74M
5
KND
Kindred Healthcare
KND
+$3.25M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$6.31M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$6.08M
3
SYK icon
Stryker
SYK
+$5.14M
4
LPNT
LifePoint Health, Inc.
LPNT
+$3.19M
5
AMGN icon
Amgen
AMGN
+$3.1M

Sector Composition

Rank Sector Weight
1 Healthcare 84.8%
2 Financials 1.81%
3 Industrials 0.84%
4 Energy 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
1
Humana
HUM
$43.7B
$9.79M 3.33%
55,000
+20,300
+59% +$3.21M
GILD icon
2
Gilead Sciences
GILD
$164B
$8.83M 3.01%
90,000
+50,300
+127% +$5.11M
AGN
3
DELISTED
Allergan plc
AGN
$8.19M 2.79%
27,500
+2,700
+11% +$770K
MCK icon
4
McKesson
MCK
$103B
$7.92M 2.69%
35,000
+300
+0.9% +$66.5K
CYH icon
5
Community Health Systems
CYH
$416M
$7.84M 2.67%
181,500
+32,186
+22% +$1.33M
BIIB icon
6
Biogen
BIIB
$30.5B
$7.39M 2.51%
17,500
-5,034
-22% -$1.98M
THC icon
7
Tenet Healthcare
THC
$21.1B
$7.18M 2.44%
145,000
+50,000
+53% +$2.34M
RAD
8
DELISTED
Rite Aid Corporation
RAD
$7.17M 2.44%
41,250
+11,570
+39% +$1.8M
HCA icon
9
HCA Healthcare
HCA
$88.7B
$7.15M 2.43%
95,000
-13,600
-13% -$977K
UHS icon
10
Universal Health Services
UHS
$10.4B
$7.06M 2.4%
60,000
-9,500
-14% -$1.05M
ZBH icon
11
Zimmer Biomet
ZBH
$19B
$7.05M 2.4%
61,800
+3,708
+6% +$423K
WCG
12
DELISTED
Wellcare Health Plans, Inc.
WCG
$6.86M 2.33%
75,000
+700
+0.9% +$58.5K
MDT icon
13
Medtronic
MDT
$110B
$5.85M 1.99%
+75,000
New +$5.68M
CELG
14
DELISTED
Celgene Corp
CELG
$5.76M 1.96%
50,000
-16,299
-25% -$1.95M
BDX icon
15
Becton Dickinson
BDX
$47B
$5.74M 1.95%
41,000
+307
+0.8% +$43K
COR icon
16
Cencora
COR
$61.7B
$5.68M 1.93%
50,000
+10,100
+25% +$1.02M
DGX icon
17
Quest Diagnostics
DGX
$26B
$5.38M 1.83%
70,000
-34,000
-33% -$2.43M
VTRS icon
18
Viatris
VTRS
$20.6B
$5.34M 1.82%
90,000
+800
+0.9% +$45.6K
AET
19
DELISTED
Aetna Inc
AET
$5.33M 1.81%
+50,000
New +$4.9M
BSX icon
20
Boston Scientific
BSX
$69.2B
$5.33M 1.81%
+300,000
New +$4.74M
TEVA icon
21
Teva Pharmaceuticals
TEVA
$40.5B
$4.98M 1.7%
80,000
+20,700
+35% +$1.2M
PRGO icon
22
Perrigo
PRGO
$1.84B
$4.97M 1.69%
30,000
+10,200
+52% +$1.63M
HNT
23
DELISTED
HEALTH NET INC
HNT
$4.8M 1.63%
79,400
– –
SHPG
24
DELISTED
Shire pic
SHPG
$4.79M 1.63%
20,000
+10,200
+104% +$2.34M
SNN icon
25
Smith & Nephew
SNN
$12.7B
$4.78M 1.63%
140,000
+1,300
+0.9% +$46K
1
2 3 4

Similar funds

VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return
MFG
Macco Financial Group Green Bay, Wisconsin $132M AUM

Sivik Global Healthcare's Q1 2015 Portfolio in Review

As of Q1 2015, Sivik Global Healthcare held 84 positions worth $294M, up 19% from $247M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Sivik Global Healthcare deployed $52.7M of net new capital in Q1 2015, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Medtronic: 75,000 shares worth $5.85M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 90% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Amgen, an estimated $3.1M trimmed.

  • Sivik Global Healthcare's largest Q1 2015 buy was Medtronic: 75,000 shares worth $5.85M.
  • Sivik Global Healthcare added most to Gilead Sciences in Q1 2015, an estimated $5.11M increase.
  • Sivik Global Healthcare's biggest Q1 2015 reduction was Amgen, cutting an estimated $3.1M.
  • Sivik Global Healthcare fully exited Allergan Inc in Q1 2015, selling an estimated $6.31M.
  • Sivik Global Healthcare's ten largest holdings make up 27% of its $294M portfolio in Q1 2015.
  • Sivik Global Healthcare opened 21 new positions and closed 9 in Q1 2015.
  • Sivik Global Healthcare's portfolio value rose 19% quarter-over-quarter to $294M.

Based on Sivik Global Healthcare's 13F filing for Q1 2015, filed 1 Apr 2015.